BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33958886)

  • 21. A randomized, controlled, split-face study of botulinum toxin and broadband light for the treatment of erythematotelangiectatic rosacea.
    Tong Y; Luo W; Gao Y; Liu L; Tang Q; Wa Q
    Dermatol Ther; 2022 May; 35(5):e15395. PubMed ID: 35187781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and Safety of Botulinum Toxin Type A in Treatment of Restless Legs Syndrome: A Systematic Review and Meta-Analysis.
    Su YC; Guo YH; Liao CL; Lin YC
    Healthcare (Basel); 2021 Nov; 9(11):. PubMed ID: 34828584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Polyphenols in Rosacea Treatment: A Systematic Review.
    Saric S; Clark AK; Sivamani RK; Lio PA; Lev-Tov HA
    J Altern Complement Med; 2017 Dec; 23(12):920-929. PubMed ID: 28650692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea.
    Bloom BS; Payongayong L; Mourin A; Goldberg DJ
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S9-16. PubMed ID: 25548852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interventions for rosacea.
    van Zuuren EJ; Graber MA; Hollis S; Chaudhry M; Gupta AK; Gover M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003262. PubMed ID: 16034895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between migraine and rosacea: Systematic review and meta-analysis.
    Christensen CE; Andersen FS; Wienholtz N; Egeberg A; Thyssen JP; Ashina M
    Cephalalgia; 2018 Jun; 38(7):1387-1398. PubMed ID: 28920449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.
    Guertler A; Jøntvedt NM; Clanner-Engelshofen BM; Cappello C; Sager A; Reinholz M
    J Cosmet Dermatol; 2020 Oct; 19(10):2627-2633. PubMed ID: 32623833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the severity of rosacea: a review.
    Gessert CE; Bamford JT
    Int J Dermatol; 2003 Jun; 42(6):444-8. PubMed ID: 12786870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Rare Dermatologic Disease in Pregnancy: Rosacea Fulminans- Case Report and Review of the Literature.
    Demir O; Tas IS; Gunay B; Ugurlucan FG
    Open Access Maced J Med Sci; 2018 Aug; 6(8):1438-1441. PubMed ID: 30159072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea.
    Johnson AW; Johnson SM
    Dermatol Ther (Heidelb); 2015 Sep; 5(3):171-81. PubMed ID: 26112098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical review of the manner in which the efficacy of therapies for rosacea are evaluated.
    Gupta AK; Chaudhry MM
    Int J Dermatol; 2003 Nov; 42(11):909-16. PubMed ID: 14636212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for rosacea.
    van Zuuren EJ; Graber MA; Hollis S; Chaudhry M; Gupta AK
    Cochrane Database Syst Rev; 2004; (1):CD003262. PubMed ID: 14974010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review of the Diagnostic and Therapeutic Gaps in Rosacea Management: Consensus Opinion.
    Del Rosso J; Baldwin H; Bhatia N; Chavda R; York JP; Harper J; Hougeir FG; Jackson JM; Noor O; Rodriguez DA; Schlesinger T; Weiss J
    Dermatol Ther (Heidelb); 2024 Feb; 14(2):271-284. PubMed ID: 38194021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interventions for rosacea.
    van Zuuren EJ; Kramer S; Carter B; Graber MA; Fedorowicz Z
    Cochrane Database Syst Rev; 2011 Mar; (3):CD003262. PubMed ID: 21412882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosacea Treatment: Review and Update.
    Zhang H; Tang K; Wang Y; Fang R; Sun Q
    Dermatol Ther (Heidelb); 2021 Feb; 11(1):13-24. PubMed ID: 33170491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosacea Management.
    Abokwidir M; Feldman SR
    Skin Appendage Disord; 2016 Sep; 2(1-2):26-34. PubMed ID: 27843919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Skin Physiology Change and Safety After Intradermal Injections With Botulinum Toxin: A Randomized, Double-Blind, Placebo-Controlled, Split-Face Pilot Study in Rosacea Patients With Facial Erythema.
    Kim MJ; Kim JH; Cheon HI; Hur MS; Han SH; Lee YW; Choe YB; Ahn KJ
    Dermatol Surg; 2019 Sep; 45(9):1155-1162. PubMed ID: 30730346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatology: how to manage rosacea in skin of colour.
    Maliyar K; Abdulla SJ
    Drugs Context; 2022; 11():. PubMed ID: 35720055
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.